Brief: Alzamend Neuro Regains Compliance With Nasdaq’S Minimum Bid Price Requirement
16/11/2023 13:14
Nov 16 (Reuters) - Alzamend Neuro Inc ALZN.O :
* ALZAMEND NEURO REGAINS COMPLIANCE WITH NASDAQ’S MINIMUM
BID
PRICE REQUIREMENT
Source text for Eikon: ID:nBw2TYmWMa
Further company coverage: ALZN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alzamend Neuro
See all newsAlzamend Neuro Inc reports results for the quarter ended April 30 - Earnings Summary
Alzamend Neuro Inc expected to post a loss of 23 cents a share - Earnings Preview
Alzamend Neuro Inc expected to post a loss of 56 cents a share - Earnings Preview
Alzamend Neuro Inc reports results for the quarter ended April 30 - Earnings Summary
Alzamend Neuro Inc expected to post a loss of 67 cents a share - Earnings Preview